Trials / Recruiting
RecruitingNCT06839131
A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects.
A Randomized, Double-Blind, Placebo-Controlled, Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of SPH9788 Tablet in Chinese Healthy Subjects.
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 94 (estimated)
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate the safety of SPH9788 tablets in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SPH9788 | SPH9788 tablets administered orally |
| DRUG | Placebo | Matching placebo administered orally |
Timeline
- Start date
- 2025-03-02
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2025-02-21
- Last updated
- 2025-03-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06839131. Inclusion in this directory is not an endorsement.